Measuring the Beat: 57 Stocks Surpassing Earnings Expectations
Academic research has consistently found that corporate earnings surprises cluster around small positive values, rather than large outperformance.
Posts Tagged ‘NASDAQ:PTCT’
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2026 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to PTC Therapeutics' First Quarter 2026 Earnings Conference Call.
PTC Therapeutics (PTCT) Reports Positive Huntington’s Disease Trial Results
PTC Therapeutics, Inc. (NASDAQ:PTCT) ranks among the most profitable biotech stocks to buy now. On April 28, PTC Therapeutics, Inc.
10 Most Profitable Biotech Stocks to Buy Now
Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, surpassing both the S&P 500 and the broader market index...
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to PTC Therapeutics Fourth Quarter and Full Year 2025 Earnings Conference Call.
Morgan Stanley Is Bullish on PTC Therapeutics, Inc. (PTCT) as Small-Cap Biotech Outlook Improves
TheFly reported on January 8 that Morgan Stanley raised its price target on PTCT to $90 from $78 and reiterated an Overweight rating.
15 High Growth Mid-Cap Stocks to Buy
The US stock market is shifting as President Trump reinforces his “America First” agenda through subsidies and incentives aimed at boosting domestic manufacturing.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to PTC Therapeutics Third Quarter 2025 Earnings Conference Call.
Bank of America Securities Lifts PT on PTC Therapeutics (PTCT) to $87 From $76
PTC Therapeutics, Inc. (NASDAQ:PTCT) is one of the most profitable biotech stocks to buy.
9 Most Profitable Biotech Stocks to Buy
On October 6, StemPoint Capital CIO Michelle Ross appeared on CNBC’s ‘Closing Bell’ to talk about the biotech space.
PTC Therapeutics, Inc. (PTCT) Launches SUFIANCE for PKU
PTC Therapeutics, Inc. (NASDAQ:PTCT) is reinforcing its position in rare disease innovation with the launch of SUFIANCE (sepiapterin) for phenylketonuria (PKU).
11 Best Performing Biotech Stocks So Far in 2025
On July 8, Jared Holz of Mizuho spoke on CNBC's "Closing Bell Overtime" about whether the biotech sector is ready for a breakthrough.
11 Cheap Biotech Stocks to Buy According to Hedge Funds
Mizuho's Jared Holz appeared on CNBC's "Closing Bell Overtime" on July 8 to talk about whether the biotech industry is prepared for a breakthrough.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to PTC Therapeutics Second Quarter 2025 Earnings Conference Call.
Truist Initiates PTC Therapeutics (PTCT) Coverage with Buy Rating on Drug Launches
PTC Therapeutics, Inc. (NASDAQ:PTCT) is one of the 10 biotech stocks screaming a buy.
10 Biotech Stocks Screaming a Buy
The biotech sector has underperformed the overall market.
Billionaire David E. Shaw’s 10 Small-Cap Stock Picks with Huge Upside Potential
David E. Shaw is one billionaire investor whose record speaks for itself on Wall Street. Having founded D.E. Shaw & Co., L.P.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2025 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2025 Earnings Call Transcript May 6, 2025PTC Therapeutics, Inc. beats earnings expectations.
11 Best Gene Therapy Stocks to Buy According to Analysts
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2024 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2024 Earnings Call Transcript February 27, 2025PTC Therapeutics, Inc. beats earnings expectations.
Why PTC Therapeutics (PTCT) Stock Is Rallying Today
PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald' hiked its price target on the drug maker's shares to $113 from $76.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2024 Earnings Call Transcript
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2024 Earnings Call Transcript November 7, 2024PTC Therapeutics, Inc. beats earnings expectations.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to PTC Second Quarter 2024 Financial Results Conference Call.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript
PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2023 Earnings Call Transcript
PTC Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.24 EPS, expectations were $0.29.
Analysts on Wall Street Lower Ratings for These 5 Stocks
In this article, we discuss the 5 stocks receiving downgrades from analysts.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by and welcome to the PTC Therapeutics Third Quarter 2023 Financial Results Conference Call.
PTC Therapeutics (PTCT) Lost 16% in Q2
TimesSquare Capital Management, an equity investment management company, released its “U.S. Small Cap Growth Strategy” second-quarter investor letter.
Analysts on Wall Street Lower Ratings for These 5 Stocks
In this article, we discuss the 5 stocks receiving downgrades from analysts.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by and welcome to the PTC Second Quarter 2023 Financial Results Conference Call.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by and welcome to the PTC First Quarter 2023 Financial Results Call. All participants are in a listen-only mode.
12 High Growth Healthcare Stocks to Buy
The healthcare sector proved its mettle in 2022.
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q4 2022 Earnings Call Transcript
Operator: Good day, and welcome to the PTC Therapeutics Fourth Quarter 2022 Corporate Update and Financial Results Call.
13 Best Genomics Stocks To Buy Now
Before talking about the best genomics stocks, it is important to understand what the term actually means.
5 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
In this article, we will take a look at some important pharma stock picks of Steven Boyd's Armistice Capital.
PTC Therapeutics, Inc. (PTCT): Hedge Fund Sentiment Unchanged
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Where Do Hedge Funds Stand On PTC Therapeutics, Inc. (PTCT)?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
Do Hedge Funds Love PTC Therapeutics, Inc. (PTCT)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is PTCT Stock A Buy or Sell?
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change...
Hedge Fund and Insider Trading News: Dan Niles, Citadel LLC, Alden Global Capital, Alexco Resource Corp. (AXU), Facebook Inc (FB), Canadian National Railway (CNI), and More
Tribune Publishing Co. said it appointed a special committee to review a buyout bid proposed by its largest shareholder, New York hedge fund Alden Global Capital LLC.
Top 5 Healthcare Stocks for the Future
Below we present the list of Top 5 Healthcare Stocks for the Future. For the first half of the list and an introduction to Dr.
Hedge Fund and Insider Trading News: Jeff Smith, Dan Loeb, Warren Buffett, Toscafund Asset Management, Workday Inc (WDAY), Dicks Sporting Goods Inc (DKS), and More
Activist investor Jeff Smith pitched two new stocks at a conference on Thursday, sending shares jumping in early trading.
Hedge Funds Are Dipping Their Toes Back Into PTC Therapeutics, Inc. (PTCT)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On PTC Therapeutics, Inc. (PTCT) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Hedge Funds Are Selling PTC Therapeutics, Inc. (PTCT)
In this article we will take a look at whether hedge funds think PTC Therapeutics, Inc. (NASDAQ:PTCT) is a good investment right now.
Do Hedge Funds Love PTC Therapeutics, Inc. (PTCT)?
We hate to say this but, we told you so.
Hedge Fund Favorites vs. PTC Therapeutics, Inc. (PTCT) In 2019
We are still in an overall bull market and many stocks that smart money investors were piling into surged in 2019.
Hedge Funds Have Never Been This Bullish On PTC Therapeutics, Inc. (PTCT)
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November.
Is PTC Therapeutics, Inc. (PTCT) A Good Stock To Buy ?
We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.
Hedge Fund Resource Center
